Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Lindstrom is active.

Publication


Featured researches published by Andrew Lindstrom.


Bioorganic & Medicinal Chemistry Letters | 2012

Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors

Sergio G. Duron; Andrew Lindstrom; Celine Bonnefous; Hui Zhang; Xiaohong Chen; Kent T. Symons; Marciano Sablad; Natasha Rozenkrants; Yan Zhang; Li Wang; Nahid Yazdani; Andrew K. Shiau; Stewart A. Noble; Peter Rix; Tadimeti S. Rao; Christian A. Hassig; Nicholas D. Smith

The overproduction of nitric oxide during the biological response to inflammation by the nitric oxide synthase (NOS) enzymes have been implicated in the pathology of many diseases. By removal of the amide core from uHTS-derived quinolone 4, a new series highly potent heteroaromatic-aminomethyl quinolone iNOS inhibitors 8 were identified. SAR studies led to identification of piperazine 22 and pyrimidine 32, both of which reduced plasma nitrates following oral dosing in a mouse lipopolysaccharide challenge assay.


Archive | 2005

Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders

Cunxiang Zhao; James W. Malecha; Stewart A. Noble; Sergio G. Duron; Andrew Lindstrom; Andrew K. Shiau


Archive | 2005

Sulfonyl-substituted bicyclic compounds as modulators of PPAR

Stewart A. Noble; Guy Oshiro; James W. Malecha; Cunxiang Zhao; Carmen Ka Man Robinson; Sergio G. Duron; Michael Sertic; Andrew Lindstrom; Andrew K. Shiau; Christopher D. Bayne; Mehmet Kahraman; Boliang Lou; Steve P. Govek


Bioorganic & Medicinal Chemistry Letters | 2007

Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.

Philip J. Skinner; Martin C. Cherrier; Peter J. Webb; Young-Jun Shin; Tawfik Gharbaoui; Andrew Lindstrom; Vu Hong; Susan Y. Tamura; Huong T. Dang; Cameron Pride; Ruoping Chen; Jeremy G. Richman; Daniel T. Connolly; Graeme Semple


Archive | 2007

Quinolones useful as inducible nitric oxide synthase inhibitors

Jeffrey Roger Roppe; Celine Bonnefous; Nicholas D. Smith; Andrew Lindstrom; Stewart A. Noble; Christian A. Hassig; Joseph E. Payne; Hui Zhuang; Xiaohong Chen; Sergio G. Duron


Bioorganic & Medicinal Chemistry Letters | 2007

Agonist lead identification for the high affinity niacin receptor GPR109a

Tawfik Gharbaoui; Philip J. Skinner; Young-Jun Shin; Claudia Averbuj; Jae-Kyu Jung; Benjamin R. Johnson; Tracy Duong; Marc Decaire; Jane Uy; Martin C. Cherrier; Peter J. Webb; Susan Y. Tamura; Ning Zou; Nathalie Rodriguez; P. Douglas Boatman; Carleton R. Sage; Andrew Lindstrom; Jerry Xu; Thomas O. Schrader; Brian Smith; Ruoping Chen; Jeremy G. Richman; Daniel T. Connolly; Steven L. Colletti; James R. Tata; Graeme Semple


Archive | 2008

Diarylamine-substituted quinolones useful as inducible nitric oxide synthase inhibitors

Nicholas D. Smith; Celine Bonnefous; Hui Zhuang; Xiaohong Chen; Sergio G. Duron; Andrew Lindstrom


Archive | 2006

Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors

James W. Malecha; Andrew Lindstrom; Sergio G. Duron; David J. Thomas


Archive | 2006

Novel Compounds as Modulators of Ppar

James W. Malecha; Andrew Lindstrom; Sergio G. Duron; Steven P. Govek


Archive | 2006

Sulfonamide derivatives as modulators of ppar

James W. Malecha; Andrew Lindstrom; Sergio G. Duron; Steven P. Govek

Collaboration


Dive into the Andrew Lindstrom's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew K. Shiau

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge